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Structurally Ordered Mesoporous Carbon Nanoparticles as
Transmembrane Delivery Vehicle in Human Cancer Cells
Abstract
A structurally ordered, CMK-1 type mesoporous carbon nanoparticle (MCN) material was successfully
synthesized by using a MCM-48 type mesoporous silica nanoparticle as template. The structure of MCN was
analyzed by a series of different techniques, including the scanning and transmission electron microscopy,
powder X-ray diffraction, and N2 sorption analysis. To the best of our knowledge, no study has been reported
prior to our investigation on the utilization of these structurally ordered mesoporous carbon nanoparticles for
the delivery of membrane impermeable chemical agents inside of eukaryotic cells. The cellular uptake
efficiency and biocompatibility of MCN with human cervical cancer cells (HeLa) were investigated. Our
results show that the inhibitory concentration (IC50) value of MCN is very high (>50 μg/mL per million
cells) indicating that MCN is fairly biocompatible in vitro. Also, a membrane impermeable fluorescence dye,
Fura-2, was loaded to the mesoporous matrix of MCN. We demonstrated that the MCN material could indeed
serve as a transmembrane carrier for delivering Fura-2 through the cell membrane to release these molecules
inside of live HeLa cells. We envision that further developments of this MCN material will lead to a new
generation of nanodevices for transmembrane delivery and intracellular release applications.
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ABSTRACT
A structurally ordered, CMK-1 type mesoporous carbon nanoparticle (MCN) material was successfully synthesized by using a MCM-48 type
mesoporous silica nanoparticle as template. The structure of MCN was analyzed by a series of different techniques, including the scanning
and transmission electron microscopy, powder X-ray diffraction, and N2 sorption analysis. To the best of our knowledge, no study has been
reported prior to our investigation on the utilization of these structurally ordered mesoporous carbon nanoparticles for the delivery of membrane
impermeable chemical agents inside of eukaryotic cells. The cellular uptake efficiency and biocompatibility of MCN with human cervical
cancer cells (HeLa) were investigated. Our results show that the inhibitory concentration (IC50) value of MCN is very high (>50 µg/mL per
million cells) indicating that MCN is fairly biocompatible in vitro. Also, a membrane impermeable fluorescence dye, Fura-2, was loaded to the
mesoporous matrix of MCN. We demonstrated that the MCN material could indeed serve as a transmembrane carrier for delivering Fura-2
through the cell membrane to release these molecules inside of live HeLa cells. We envision that further developments of this MCN material
will lead to a new generation of nanodevices for transmembrane delivery and intracellular release applications.
Recent developments in designing structurally defined car-
bonaceous nanoporous materials, such as single-walled
carbon nanotubes (SWNTs), have shown potential for various
biomedical and biotechnological applications, such as cell/
tissue imaging, gene transfection, and drug delivery.1-3
However, the hydrophobic nature of these materials often
leads to a random agglomeration in water under physiological
conditions. This problem severely complicates the biocom-
patibility, circulation, and endocytosis properties of these
carbon-based nanomaterials in vitro or in vivo. To circumvent
this aggregation issue, a key prerequisite is to control the
surface properties and particle morphology of these materials
for efficient uptakes by various cell types. While exciting
progress has been made in functionalizing the graphitic
surface of SWNT with water-soluble and biologically active
moieties for cellular uptakes,1-11 to the best of our knowl-
edge, there has been no prior report on the endocytosis and
biocompatibility of other structurally ordered carbonaceous
nanoporous materials, such as ordered mesoporous carbons
(OMCs).
The high surface area (>1000 m2/g), large pore volume
(>1 cm3/g), and uniform mesoporous structures of OMC
materials offer many advantages for biotechnological ap-
plications.12-18 However, the particle size and shape of most
OMCs are not well defined. The conventional OMCs are
amorphous polydisperse materials with a large average
particle size (>1 µm), which cannot be endocytosed by live
cells. Also, given that the typical size of OMCs is within
the size window of bacteria, these materials could potentially
trigger acute immune response in vivo. This morphological
deficiency of OMCs derives from the fact that these
carbonaceous materials are typically the replications from
the hard template silicas with interconnecting mesopores. In
general, OMC is prepared by infiltrating the mesopores of a
silica template with a carbon precursor, followed by a high-
temperature carbonization to yield a silica-carbon composite
material.12-14 The silica template is later dissolved and
removed under either acidic or basic conditions.12-14 On the
basis of this synthetic approach, the morphology of OMCs
is dictated by the size and shape of the silica “mold”.
To overcome this morphology issue and to develop an
OMC material with high biocompatibility, we report herein
on the synthesis of a monodisperse, CMK-1 type mesoporous
carbon nanoparticle (MCN) material with an average particle* Corresponding author: e-mail, vsylin@iastate.edu; phone, (515) 294-3135; fax, (515) 294-0105.
NANO
LETTERS
2008
Vol. 8, No. 11
3724-3727
10.1021/nl801976m CCC: $40.75  2008 American Chemical Society
Published on Web 10/28/2008
size of 150 nm. As detailed below, we have discovered that
MCN is biocompatible and could be efficiently endocytosed
by human cervical cancer cells (HeLa). Furthermore, our
experimental data indicated that this MCN material could
serve as a transmembrane delivery vehicle for the intracel-
lular release of a cell membrane impermeable fluorescence
dye, Fura-2, inside human cervical cancer cells (HeLa) as
depicted in Scheme 1. While we and other groups have
demonstrated that mesoporous silica nanoparticles can serve
as effective carriers for efficient transmembrane drug deliv-
ery,19-28 mesoporous carbon nanoparticles have higher
surface areas and pore volumes compared to mesoporous
silicas, which are advantageous for drug loading. In addition,
a recent report has shown that the cytotoxicity of carbon
nanoparticles is lower than that of silica nanoparticles.29,30
In contrast to the hydrophilic silicate surface of mesoporous
silicas, the surface of MCN is comprised of graphenes and
is hydrophobic. Most of hydrophobic drug molecules could
be easily loaded inside of the mesoporous matrix of MCN
in large quantities.
To prepare the MCN material, we first synthesized a
MCM-48 type mesoporous silica nanoparticle (MSN) mate-
rial as the structure-directing template via a modified Sto¨ber
method.31 Cetyltrimethylammonium bromide (CTAB; 1.0 g)
and a triblock copolymer (Pluronic F127, EO106PO70EO106;
4.0 g) were mixed in 298 mL of H2O/NH3/EtOH solution
(NH4OH(aq) (2.8 wt %)/EtOH ) 2.5/1 (v/v)). Tetraethyl
orthosilicate (TEOS; 3.6 g) was added into the solution at
Figure 1. Low-magnification TEM images of (a) mesoporous silica
MCM-48 nanoparticles and (b) mesoporous carbon nanoparticle
(MCN) materials. High-magnification TEM images of (c) MCM-
48 nanoparticle and (d) MCN material with the corresponding
Fourier diffactograms (insets).
Scheme 1. Schematic Representation of the Endocytosis
of Mesoporous Carbon Nanoparticles (MCNs) and the
Intracellular Release of Fura-2 Molecules
Figure 2. (a) Powder XRD patterns of MCN (top) and the calcined,
MCM-48 type MSN silica template (bottom). (b) N2 sorption
isotherm and the pore size analysis with adsorption branch using
the BJH algorithm (inset) of MCN.
Table 1. Structural Properties of MCM-48 Mesoporous
Silica Nanoparticles and Ordered Mesoporous Carbon
Nanoparticle MCNs from Nitrogen Adsorption Dataa
sample SBET (m2 g-1) Vt (cm3 g-1) wBHJ (nm)
MCM-48 1278 0.96 2.3
MCN 2034 1.2 2.4
a SBET, the BET specific surface area calculated in the range of relative
pressures from 0.05 to 0.2; Vt, the total pore volume calculated at the relative
pressure of about 0.95; wBJH, the diameter of mesopores calculated using
the BJH method.
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room temperature. After vigorous stirring for 1 min, the
reaction mixture was kept under static condition for 1 day
at room temperature for the complete condensation of silica.
The resulting solid MSN product was isolated by centrifuge,
washed with copious water, and dried at 70 °C in air. To
synthesize MCN, the surface of MSN was first converted to
an aluminosilicate form via a previously reported method.32
As described in the Experimental Section in the Supporting
Information, the aluminated MSN was infiltrated by furfuryl
alcohol at room temperature, followed by polymerization and
carbonization at elevated temperatures under vacuum. The
silica template was removed by washing the composite with
HF(aq) to yield the desired MCN material.
The structure of MCN was analyzed by a series of different
techniques, including the scanning and transmission electron
microscopy (SEM and TEM), powder X-ray diffraction
(XRD), and N2 sorption analysis. As depicted in Figure 1,
the MCN material consisted of monodisperse (100s200 nm)
spherical nanoparticles. As showed in Figure 1a, the TEM
micrograph of MCN showed the exact replication of the
whole particle morphology (spherical particles). Also, a
tetragonal I41/a (or lower) mesoporous structure, which is
the replication of the cubic Ia-3d porous morphology of MSN
template, was also observed in Figure 1b. The high-
magnification TEM images of MSN and MCN materials
(Figure 1, panels c and d) confirmed the highly ordered
mesoporous structures throughout the entire particle of these
materials. As depicted in Figure 2a, the XRD patterns of
MSN and MCN further revealed the successful transforma-
tion from the cubic Ia-3d (MCM-48 type) to the tetragonal
I41/a (or lower) mesoporous structure after the carbon
replication process.32 The N2 sorption isotherm (Figure 2b)
exhibited two capillary condensation steps at P/P0 )
0.18-0.3 and >0.95, which could be attributed to the N2
condensation that took place at the internal mesopores and
the interparticle voids, respectively. We found that MCN has
large BET surface area (∼2000 m2/g) and pore volume (1.2
cm3/g) (Table 1). The BJH pore size distribution showed an
average pore diameter of 2.4 nm.
To investigate the cell membrane permeability of MCN,
we introduced an aqueous suspension of MCN (10 µg/mL)
to a culture (∼1 × 105 cells) of human cervical cancer cells
(HeLa) in D-10 media. The endocytosis of MCN was
examined by differential interference contrast (DIC) micros-
copy.33 After 24 h of incubation, DIC images (Figure 3) of
the live cells with different focal depth along the Z-axis
showed that MCNs (black aggregates) were indeed internal-
ized by HeLa cells. The biocompatibility of MCN was
evaluated by incubating HeLa cells with MCN suspensions
Figure 3. DIC micrographs and schematic representations of MCNs
endocytosed by a HeLa cell. The focal plane was varied along the
Z-axis from the top (a) to bottom (c) of the cell.
Figure 4. (a) Viability test of HeLa cells with different concentra-
tions of MCN after 48 h of incubation. (b) Release profile of Fura-2
fluorescein from MCNs in D-10 medium at room temperature.
Figure 5. (a) Bright-field image and (b) confocal fluorescence
microscopy image of Fura-2/MCN containing HeLa cells.
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of different concentrations (0, 1, 10, 25, and 50 µg/mL) in
growth media for 48 h. These cells were analyzed by flow
cytometry as detailed in the Experimental Section. Interest-
ingly, no growth inhibition was found at concentrations
below 10 µg/mL. As shown in Figure 4a, the high inhibitory
concentration (IC50) value (>50 µg/mL per million cells)
indicated that MCN is very biocompatible in vitro.
To investigate the efficacy of using MCN as a transmem-
brane delivery carrier for intracellular release of drugs or
other biogenic molecules, a cell membrane impermeable
fluorescent dye (Fura-2) was loaded into MCN to yield a
composite material (Fura-2/MCN). As shown in Figure 4b,
Fura-2 could indeed be released efficiently from MCN in
D-10 medium. A fast release of Fura-2 was observed within
the initial 20 min, followed by a slow concentration increase
before reaching the plateau in 2 h. A large amount (10.6
µmol/g) of Fura-2 was released from MCN over the period
of 2 h. These results suggested that the release of Fura-2
was governed by a simple diffusion process from a uniformed
mesoporous matrix.
To investigate the property of intracellular release, the
Fura-2/MCN nanoparticles were suspended in PBS (pH 7.4)
at a concentration of 1 mg/mL. The suspension (150 µL)
was added to a cell culture of HeLa in 3 mL of growth media,
followed by a 12 h incubation at 37 °C under 5% CO2
atmosphere. The cells were then isolated, washed with
copious PBS buffer, and transferred to a microscope slide
with 20 µL of fresh growth media for immediate observation
under a confocal fluorescent microscope. As depicted in
Figure 5a, the bright-field micrograph showed that the MCN
particles were indeed internalized by HeLa cells and formed
aggregates in the cytoplasm. The intense green fluorescence
illustrated in the confocal fluorescence image (Figure 5b)
clearly indicated that Fura-2 molecules were indeed delivered
through the cell membrane of HeLa by MCN and were
released inside the cells. To confirm this result, Fura-2 was
introduced to the HeLa cell culture without the presence of
MCN. The cells were examined under the same experimental
condition by confocal fluorescence microscopy. No fluores-
cence was observed inside the cell bodies.
In conclusion, we have demonstrated that a structurally
stable mesoporous carbon nanoparticle (MCN) material with
high surface area and defined particle and pore morphology
could be successfully synthesized. We discovered that this
carbonaceous nanoparticle material could efficiently penetrate
the plasmic membrane of live HeLa cells with low cytotox-
icity. Also, our data indicated that these MCN nanoparticles
could serve as effective transmembrane delivery carriers for
intracellular release of a cell-membrane-impermeable fluo-
rescence dye, Fura-2. We envision that further development
of this type of MCN material will lead to a new generation
of nanodevices for a variety of biotechnological and bio-
medical applications.
Acknowledgment. This study was supported by the U.S.
National Science Foundation (CHE-0239570 and CHE-
0809521) and the U.S. DOE Ames Laboratory through the
office of Basic Energy Sciences under Contract No. DE-
AC02-07CH11358.
Supporting Information Available: The detailed experi-
mental procedures for the synthesis of MCN, characterization
measurements, endocytosis, and Fura-2 release test, SEM
images of MCM-48 nanoparticles and MCN, and energy-
dispersive X-ray (EDX) spectroscopy of MCN. This material
is available free of charge via the Internet at http://
pubs.acs.org.
References
(1) Bianco, A.; Kostarelos, K.; Partidos, C. D.; Prato, M. Chem. Commun.
2005, (5), 571–577.
(2) Kam, N. W. S.; Dai, H. Phys. Status Solidi B 2006, 243 (13), 3561–
3566.
(3) Liu, Y.; Wang, H. Nat. Nanotechnol. 2007, 2 (1), 20–21.
(4) Pantarotto, D.; Briand, J.-P.; Prato, M.; Bianco, A. Chem. Commun.
2004, (1), 16–17.
(5) Kam, N. W. S.; Jessop, T. C.; Wender, P. A.; Dai, H. J. Am. Chem.
Soc. 2004, 126 (22), 6850–6851.
(6) Kam, N. W. S.; Dai, H. J. Am. Chem. Soc. 2005, 127 (16), 6021–
6026.
(7) Bottini, M.; Cerignoli, F.; Dawson, M. I.; Magrini, A.; Rosato, N.;
Mustelin, T. Biomacromolecules 2006, 7 (8), 2259–2263.
(8) Kam, N. W. S.; Liu, Z.; Dai, H. Angew. Chem., Int. Ed. 2006, 45 (4),
577–581.
(9) Feazell, R. P.; Nakayama-Ratchford, N.; Dai, H.; Lippard, S. J. J. Am.
Chem. Soc. 2007, 129 (27), 8438–8439.
(10) Liu, Z.; Sun, X.; Nakayama-Ratchford, N.; Dai, H. ACS Nano 2007,
1 (1), 50–56.
(11) Liu, Y.; Wu, D.-C.; Zhang, W.-D.; Jiang, X.; He, C.-B.; Chung, T. S.;
Goh, S. H.; Leong, K. W. Angew. Chem., Int. Ed. 2005, 44 (30), 4782–
4785.
(12) Ryoo, R.; Joo, S. H.; Kruk, M.; Jaroniec, M. AdV. Mater. 2001, 13
(9), 677–681.
(13) Ryoo, R.; Joo, S. H. Stud. Surf. Sci. Catal. 2004, 148, 241–260.
(14) Lee, J.; Kim, J.; Hyeon, T. AdV. Mater. 2006, 18 (16), 2073–2094.
(15) Hartmann, M. Chem. Mater. 2005, 17 (18), 4577–4593.
(16) Vinu, A.; Miyahara, M.; Mori, T.; Ariga, K. J. Porous Mater. 2006,
13 (3-4), 379–383.
(17) Vinu, A.; Hossain, K. Z.; Satish Kumar, G.; Ariga, K. Carbon 2006,
44 (3), 530–536.
(18) Ariga, K.; Vinu, A.; Miyahara, M.; Hill, J. P.; Mori, T. J. Am. Chem.
Soc. 2007, 129 (36), 11022–11023.
(19) Radu, D. R.; Lai, C.-Y.; Jeftinija, K.; Rowe, E. W.; Jeftinija, S.; Lin,
V. S. Y. J. Am. Chem. Soc. 2004, 126 (41), 13216–13217.
(20) Giri, S.; Trewyn, B. G.; Stellmaker, M. P.; Lin, V. S. Y. Angew. Chem.,
Int. Ed. 2005, 44 (32), 5038–5044.
(21) Slowing, I.; Trewyn, B. G.; Lin, V. S.-Y. J. Am. Chem. Soc. 2006,
128 (46), 14792–14793.
(22) Slowing, I. I.; Trewyn, B. G.; Giri, S.; Lin, V. S. Y. AdV. Funct. Mater.
2007, 17 (8), 1225–1236.
(23) Slowing, I. I.; Trewyn, B. G.; Lin, V. S. Y. J. Am. Chem. Soc. 2007,
129 (28), 8845–8849.
(24) Torney, F.; Trewyn, B. G.; Lin, V. S. Y.; Wang, K. Nat. Nanotechnol.
2007, 2 (5), 295–300.
(25) Slowing, I. I.; Vivero-Escoto, J. L.; Wu, C.-W.; Lin, V. S. Y. AdV.
Drug DeliVery ReV. 2008, 60 (11), 1278–1288.
(26) Liu, H.-M.; Wu, S.-H.; Lu, C.-W.; Yao, M.; Hsiao, J.-K.; Hung, Y.;
Lin, Y.-S.; Mou, C.-Y.; Yang, C.-S.; Huang, D.-M.; Chen, Y.-C. Small
2008, 4 (5), 619–26.
(27) Lu, J.; Liong, M.; Sherman, S.; Xia, T.; Kovochich, M.; Nel, A. E.;
Zink, J. I.; Tamanoi, F. NanoBiotechnology 2007, 3 (2), 89–95.
(28) Lu, J.; Choi, E.; Tamanoi, F.; Zink, J. I. Small 2008, 4 (4), 421–426.
(29) Yan, A.; Lau, B. W.; Weissman, B. S.; Kulaots, I.; Yang, N. Y. C.;
Kane, A. B.; Hurt, R. H. AdV. Mater. (Weinheim, Ger.) 2006, 18 (18),
2373–2378.
(30) Xu, Z. P.; Zeng, Q. H.; Lu, G. Q.; Yu, A. B. Chem. Eng. Sci. 2006,
61 (3), 1027–1040.
(31) Schumacher, K.; Ravikovitch, P. I.; Du Chesne, A.; Neimark, A. V.;
Unger, K. K. Langmuir 2000, 16 (10), 4648–4654.
(32) Kim, T.-W.; Solovyov, L. A. J. Mater. Chem. 2006, 16 (15), 1445–
1455.
(33) Li, H.-W.; McCloskey, M.; He, Y.; Yeung, E. S. Anal. Bioanal. Chem.
2007, 387 (1), 63–69.
NL801976M
Nano Lett., Vol. 8, No. 11, 2008 3727
